Free Trial

SIGA Technologies Q4 2023 Earnings Report

SIGA Technologies logo
$5.55 -0.02 (-0.36%)
As of 03/28/2025 04:00 PM Eastern

SIGA Technologies EPS Results

Actual EPS
$1.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

SIGA Technologies Revenue Results

Actual Revenue
$116.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

SIGA Technologies Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Remove Ads

SIGA Technologies Earnings Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Q4 2024 SIGA Technologies Inc Earnings Call
See More SIGA Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SIGA Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SIGA Technologies and other key companies, straight to your email.

About SIGA Technologies

SIGA Technologies (NASDAQ:SIGA), a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

View SIGA Technologies Profile

More Earnings Resources from MarketBeat